Two start-ups announced funding on 15 October 2026 to let holders of tokenised funds get cash out faster. Both treat exit as a paid service, and that has a lesson for anyone planning tokenised equity.

TERN has opened applications for a UK fund investing £50,000 to £100,000 in refugee-founded businesses. The starting pot is £300,000 against a planned £10 million.

Oxford photonics company Salience Labs has raised a $125m Series B that includes £10m from the British Business Bank, announced on 14 October 2026, set against the Bank's other recent announcements.

An early assessment by SQW found six British Business Bank regional funds made 951 investments and drew £233 million of private money by September 2025. The evidence shows who gets first institutional money, and little yet on what follows.

The British Business Bank has committed £3 million to TSP Ventures through its Regional Angels Programme. It is the smallest of three such commitments traced this year, which may point to the programme spreading across more angel groups.

London's Scarlet has raised $50 million to speed up approval of AI medical devices, and its figures show how review time shapes a founder's release pace.

SEIS raised a record 276 million pounds in 2024-25 while EIS plateaued and VCT relief fell to 20 per cent. This is what is confirmed about the 28 October Budget, and what UK founders can ask before it.

Every week this publication covers another piece of UK market infrastructure edging tokenisation from pilot toward permanence, a sandbox settlement, a feedback statement, a new PISCES admission. Almost none of it touches the part of the UK's startup finance system that most badly needs a liquidity answer: the earliest, smallest, highest risk shareholdings created under the Seed Enterprise Investment Scheme. SEIS is the most generous tax incentive available to any investor

Six months after a poll of UK founders and investors on equity tokenisation, the plumbing has arrived but the case studies have not. Who is ready, who should wait, and what comes next.

The British Business Bank has committed £10 million to Fuel Ventures through its Regional Angels Programme, to widen early stage investment and further funding for portfolio companies.

Spiko, the London and Paris tokenised cash fund issuer, raised a $90 million Series B led by NEA on 6 October 2026, taking its total funding to $120 million.

The British Business Bank joined a $20 million round for Living Optics, an Oxford University spinout making hyperspectral cameras, led by BRV Capital Management and announced on 5 October 2026.

Noah, a UK stablecoin payments start-up, closed a $38m seed round on 7 October 2026, made up of $22m raised last year and a $16m extension.

Seed deals are down and SEIS funds keep selling out. For founders running social enterprises, community interest companies and purpose-led businesses, there's a large pool of non-dilutive money that rarely comes up in startup circles.

Chris Woolard has spent most of his career deciding how UK financial markets get regulated. This month he published his first report on how they get rebuilt.

Seed stage deal volumes in the UK fell 27 per cent year on year, according to the British Business Bank's Small Business Equity Tracker 2026, even as overall equity investment was propped up by a relatively small number of large AI transactions. Against that backdrop, professionally managed Seed Ent

The amount was not disclosed and neither was the stake. That combination is normal for corporate strategic investment and worth understanding before a founder accepts one.

The milestone combines public and private money. The fund's own capital accounts for 44 million pounds of it, which tells a founder more about what is still available than the headline does.

Investment into UK start-ups more than doubled in the first seven months of 2026 compared with the same period a year earlier, according to new analysis from GlobalData. Total capital deployed rose 113 per cent year on year, even as the number of deals stayed largely flat. For founders who can comma

The round is one of the largest into a UK life sciences company this year, and the capital setting its price came from the United States.